-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hangzhou, October 27, 2021/PRNewswire/ - On October 17, the transcatheter aortic valve repair system introduced by Hangzhou Qiming Medical Instrument Co.
This application was successfully completed by the team of Professor Dong Nianguo from Union Hospital of Tongji Medical College of Huazhong University of Science and Technology, with the cooperation of Professor Wu Yongjian from Fuwai Hospital of Chinese Academy of Medical Sciences, Professor Peng Xiaoping and Professor Jiang Yu from the First Affiliated Hospital of Nanchang University
It is worth mentioning that this operation also used Qiming Medical's another innovative device-TriGUARD3™ anti-embolism distal brain protection device (hereinafter referred to as "TriGUARD3™")
The treatment achieved the expected results, the patient's hemodynamics were stable, the entire repair process did not need to be performed under pacing conditions, and the aortic regurgitation did not aggravate after the repair was completed
Mr.
Leaflex™ is a unique mechanical device that can engrave the calcified part of the valve from multiple angles, rupture the calcium deposits, restore the flexibility of the valve leaflets, increase the movement of the valve leaflets, and improve the hemodynamic indicators of the valve
Leaflex™ was developed by Pi-Cardia Ltd.
In Europe, the first human study of Leaflex™ has been completed in six clinical centers, proving the function and safety of the device
Source: Hangzhou Qiming Medical Equipment Co.
